Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Rongsheng Pharmaceutical is a specialized pharmaceutical manufacturer and a key subsidiary of Sinopharm Modern Pharmaceutical, based in Jiaozuo, Henan Province, China. The company is a major production hub for injectable formulations, including small-volume injections, large-volume infusions, and lyophilized powders. Its extensive product portfolio focuses on therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-infectives, and emergency medicine. Operating multiple GMP-certified production lines, Sinopharm Rongsheng is recognized for its large-scale manufacturing capabilities and commitment to international quality standards. As a core member of the China National Pharmaceutical Group (Sinopharm), it plays a vital role in the supply of essential medicines both within China and to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 国药集团容生制药.